Skip to main content
Fig. 3 | BMC Veterinary Research

Fig. 3

From: The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs

Fig. 3

Western blot analysis: a) western blot appearance and b) semi-quantified data graphs of A (n = 3; three independent experiments). Phosphorylation of the dual mutant KIT was only suppressed at a masitinib concentration of 10 μM. * indicates significant difference (P < 0.01; Student t-test)

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us